Sign-up for our newsletter
Protocols & Methods
Reagents & Resources
IMPC / KOMP Data
University of California-San Francisco
Development and Optimization of Near Single Cell Proteome of Diabetic Nephropathy
Diabetes is projected to be a major health crisis in near future. People with diabetes are more likely to have both microvascular and macrovascular complications, including diabetic kidney disease (DKD). The incidence of occurring DKD on diabetic individuals is estimated to be ~40% and triggers kidney-specific diseases such as glomerular hypertrophy, glomerulosclerosis, and tubulointerstitial inflammation and fibrosis. Despite current therapies, there is an urgent need to understand the risk of disease onset and progression. Building of a molecular/cellular atlas integrating imaging and “omics” datasets provides a promise for a comprehensive picture of kidney at pertinent clinical endpoints. This carefully designed study brings a team of expert investigators who have access to the best facilities in carrying the proposed work. We aim to develop and generate proteomics data at near single cell level interrogating the cells captured from glomeruli. Through this study, we will be able dive deep into the DKD-associated processes in glomerular cells such as mesangial expansion, glomerular basement membrane thickening and fibrosis. The protocol developed through this study will be helpful to capture more kidney cell types for proteome profiling in the future. The unbiased and high throughput interrogation of glomerular cells at different clinical endpoints of DKD (stages I-IV) will generate proteome data for hypothesis generation. The additional contribution is that this proteome data will be instrumental in providing a dimension among many dimensions of molecular integration through imaging and other omics such as transcriptomics and metabolomics. The hypotheses generated could be applied to larger studies with funding from NIH and non-NIH sources.
Drag a column header and drop it here to group by that column
Development and Optimization of Near Single Cell Proteome of Diabetic Nephropathy (Sigdel, Tara)
View Progress Report Document
No uploaded documents found.
No publications found.
No uploaded documents found.
No protocols found.
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
The DiaComp Nephropathy Committee has the principal function of furthering the mission of the consortium with regard to diabetic kidney disease.
Curation Flag Information
New comment to be added:
No records to display.
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!